Exane Derivatives P Lx Pharma Inc. Transaction History

Exane Derivatives

  • $157 Million
  • Q2 2022

A detailed history of Exane Derivatives transactions in P Lx Pharma Inc. stock. As of the latest transaction made, Exane Derivatives holds 6,575 shares of PLXP stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,575
Previous 13,407 50.96%
Holding current value
$0
Previous $54,000 72.22%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022
SELL
$1.9 - $4.18 $12,980 - $28,557
-6,832 Reduced 50.96%
6,575 $15,000
Q1 2022

Apr 22, 2022
BUY
$3.54 - $8.3 $47,460 - $111,278
13,407 New
13,407 $54,000

Others Institutions Holding PLXP

# of Institutions
4
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About PLx Pharma Inc.

PLXP Quotes by TradingView
  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email